Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry
Ásta Theódórsdóttir(Rigshospitalet), Zsolt Illés(Universität Hamburg), Carl-Fredrik Malmberg(Odense University Hospital), Matthias Kant(Sygehus Sønderjylland), Iver A Norberg(Odense University Hospital), Peter Vestergaard Rasmussen(Aarhus University Hospital), Mathias Falck Schmidt(Copenhagen University Hospital), Jette Lautrup Frederiksen(University of Copenhagen), Birgit Debrabant(University of Southern Denmark), Danny Bech(Regionshospitalet Viborg), Karen Schreiber(Guy's and St Thomas' NHS Foundation Trust), Finn Sellebjerg(Danish Multiple Sclerosis Center), Victoria Hansen(Aalborg University Hospital), Melinda Magyari(University of Copenhagen)
Cited by 21
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572
EFNS guidelines on diagnosis and management of neuromyelitis optica
|European Journal of Neurology|2010|469